Table 22-5.
Time Trends in GWTG-Stroke Quality-of-Care Measures, 2006 to 2012
| Quality-of-Care Measure | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 |
|---|---|---|---|---|---|---|---|
| IV tPA in patients who arrived ≤2 h after symptom onset, treated ≤3 h* | 55.8 | 60.2 | 63.9 | 73.1 | 76.2 | 78.3 | 82.0 |
| IV tPA in patients who arrived <3.5 h after symptom onset, treated ≤4.5 h | … | … | … | … | 42.5 | 57.9 | 60.4 |
| IV tPA door-to-needle time ≤60 min | 22.5 | 24.9 | 25.9 | 28.0 | 29.5 | 33.8 | 39.9 |
| Thrombolytic complications: IV tPA and life-threatening, serious systemic hemorrhage | 20.8 | 17.3 | 16.1 | 15.1 | 13.1 | 15.7 | 16.5 |
| Antithrombotics <48 h after admission* | 94.8 | 95.8 | 96.0 | 96.2 | 96.3 | 96.7 | 96.9 |
| DVT prophylaxis by second hospital day* | 85.3 | 88.9 | 92.2 | 92.7 | 92.2 | 93.5 | 98.4 |
| Antithrombotics at discharge* | 94.1 | 95.1 | 97.0 | 97.8 | 97.7 | 98.1 | 97.8 |
| Anticoagulation for AF at discharge* | 88.2 | 89.5 | 93.1 | 93.5 | 93.5 | 93.1 | 93.4 |
| Therapy at discharge if LDL cholesterol >100 mg/dL or LDL cholesterol not measured or on therapy at admission* | 70.3 | 76.3 | 82.1 | 86.2 | 88.1 | 89.8 | 94.5 |
| Counseling for smoking cessation* | 86.1 | 92.2 | 94.3 | 96.2 | 96.7 | 97.0 | 96.8 |
| Lifestyle changes recommended for BMI >25 kg/m2 | 42.5 | 45.7 | 51.7 | 57.3 | 57.8 | 57.8 | 57.2 |
| Composite quality-of-care measure | 85.9 | 88.9 | 91.7 | 93.3 | 93.7 | 94.4 | 96.3 |
Values are percentages.
In-hospital mortality for the 2012 patient population was 6.4%, and mean length of hospital stay was 5.2 d (median 3.0 d).
AF indicates atrial fibrillation; BMI, body mass index; DVT, deep vein thrombosis; GWTG-Stroke, Get With The Guidelines–Stroke; IV, intravenous; LDL, low-density lipoprotein; and tPA, tissue-type plasminogen activator.
*
Indicates the 7 key achievement measures targeted in GWTG-Stroke.